Interno di un nuraghe
Crescenzi, M, Napolitano, M, Carbonari, M, Antonelli, A, Petrinelli, P, Gaetano, C, and Fiorilli, M. Establishment of a new Epstein-Barr virus-immortalized cell line from chronic lymphocytic leukemia with trisomy of chromosome 12 that produces monoclonal IgM against a sheep RBC antigen. Blood 71:9-12, 1988.
Crescenzi, M, Seto, M, Herzig, GP, Weiss, PD, Griffith, RC, and Korsmeyer, SJ. Thermostable DNA Polymerase Chain Amplification of t(14;18) Chromosome Breakpoints and Detection of Minimal Residual Disease. Proc Natl Acad Sci USA 85:4869-4873, 1988.
Crescenzi, M. B-cell lymphoma: t(14;18) chromosome rearrangement. In: Innis, MA, DH Gelfand, JJ Sninsky and TJ White (eds). PCR protocols: a guide to methods and applications. Academic Press: New York (1990). pp 392-398.
Miki, T, Fleming, TP, Crescenzi, M, Molloy, CJ, Blam, SB, Reynolds, SH, and Aaronson, SA. Development of a highly efficient expression cDNA cloning system: Application to oncogene isolation. Proc Natl Acad Sci USA 88:5167-5171, 1991.
Marti, GE, Zenger, V, Brown, M, Marti, DM, Melo, JV, Crescenzi, M, Dadey, B, Han, T, Bertin, P, Caporaso, NE, and Noguchi, P. Antigenic expression of B-cell chronic lymphocytic leukemic cell lines. Leuk Lymphoma 7:497-504, 1992.
Crescenzi, M, Crouch, D, and Tato', F. Effects of myc expression on mouse myoblasts are reversed in mixed culture with normal cells. In: Rifkind, RA (ed). The pharmacology of cell differentiation. Elsevier Science Publishers: Amsterdam (1993). pp 157-166.
Crescenzi, M, Crouch, DH, and Tato', F. Transformation by myc prevents fusion but not biochemical differentiation of C2C12 myoblasts: mechanisms of phenotypic correction in mixed culture with normal cells. J Cell Biol 125:1137-1145, 1994.
Falcioni, R, Antonini, A, Nistico', P, Di Stefano, S, Crescenzi, M, Natali, PG, and Sacchi, A. a6b4 and a6b1 integrins associate with ErbB-2 in human carcinoma cell lines. Exp Cell Res 236:76-85, 1997.
Moretti, F, Farsetti, A, Soddu, S, Misiti, S, Crescenzi, M, Filetti, S, and Andreoli, M. p53 re-expression inhibits proliferation and restores differentiation of human thyroid anaplastic carcinoma cells. Oncogene 14:729-740, 1997.
Scardigli, R, Bossi, G, Blandino, G, Crescenzi, M, Soddu, S, and Sacchi, A. Expression of exogenous wt-p53 does not affect normal hematopoiesis: implications for bone marrow purging. Gene Therapy 4:1371-1378, 1997.
Rizzo, MG, Zepparoni, A, Cristofanelli, B, Scardigli, R, Crescenzi, M, Blandino, G, Giuliacci, S, Ferrari, S, Soddu, S, and Sacchi, A. Wt-p53 action in human leukaemia cell lines corresponding to different stages of differentiation. Brit J Cancer 77:1429-1438, 1998.
Giannini, G, Di Marcotullio, L, Ristori, E, Zani, M, Crescenzi, M, Scarpa, S, Piaggio, G, Vacca, A, Peverali, FA, Diana, F, Screpanti, I, Frati, L, and Gulino, A. HMGI(Y) and HMGI-C genes are expressed in neuroblastoma cell lines and tumors and affect retinoic acid responsiveness. Cancer Res 59:2484-2492, 1999.
D'Orazi, G, Marchetti, A, Crescenzi, M, Coen, S, Sacchi, A, and Soddu, S. Exogenous wt-p53 protein is active in transformed cells but not in their non-transformed counterparts: implications for cancer gene therapy without tumor targeting. J Gene Med 2:11-21, 2000.
Moretti, F, Nanni, S, Farsetti, A, Narducci, M, Crescenzi, M, Giuliacci, S, Sacchi, A, and Pontecorvi, A. Effects of exogenous p53 transduction in thyroid tumor cells with different p53 status. J Clin Endocrinol Metab 85:302-308, 2000.
Colussi, C, Fiumicino, S, Giuliani, A, Rosini, S, Musiani, P, Macri, C, Potten, CS, Crescenzi, M, and Bignami, M. 1,2-Dimethylhydrazine-Induced Colon Carcinoma and Lymphoma in msh2(-/-) Mice. J Natl Cancer Inst 93:1534-1540, 2001.
Crescenzi, M, and Giuliani, A. The main biological determinants of tumor line taxonomy elucidated by a principal component analysis of microarray data. FEBS Letters 507:114-118, 2001.
Giannini, G, Ristori, E, Cerignoli, F, Rinaldi, C, Zani, M, Viel, A, Ottini, L, Crescenzi, M, Martinotti, S, Bignami, M, Frati, L, Screpanti, I, and Gulino, A. Human MRE11 is inactivated in mismatch repair-deficient cancers. EMBO Rep 3:248-254, 2002.
Bossi, G, Mazzaro, G, Porrello, A, Crescenzi, M, Soddu, S, and Sacchi, A. Wild-type p53 gene transfer is not detrimental to normal cells in vivo: implications for tumor gene therapy. Oncogene 23:418-425, 2004.
Nicassio, F, Bianchi, F, Capra, M, Vecchi, M, Confalonieri, S, Bianchi, M, Pajalunga, D, Crescenzi, M, Bonapace, IM, and Di Fiore, PP. A cancer-specific transcriptional signature in human neoplasia. J Clin Invest 115:3015-3025, 2005.
Casorelli, I, Tenedini, E, Tagliafico, E, Blasi, MF, Giuliani, A, Crescenzi, M, Pelosi, E, Testa, U, Peschle, C, Mele, L, Diverio, D, Breccia, M, Lo Coco, F, Ferrari, S, and Bignami, M. Identification of a molecular signature for leukemic promyelocytes and their normal counterparts: Focus on DNA repair genes. Leukemia 20:1978-1988, 2006.
Marzi, MJ, Puggioni, EM, Dall'olio, V, Bucci, G, Bernard, L, Bianchi, F, Crescenzi, M, Di Fiore, PP, and Nicassio, F. Differentiation-associated microRNAs antagonize the Rb-E2F pathway to restrict proliferation. J Cell Biol 199:77-95, 2012.
Fosso, B, Santamaria, M, D'Antonio, M, Lovero, D, Corrado, G, Vizza, E, Passaro, N, Garbuglia, AR, Capobianchi, MR, Crescenzi, M, Valiente, G, and Pesole, G. MetaShot: an accurate workflow for taxon classification of host-associated microbiome from shotgun metagenomic data. Bioinformatics, 2017.
Passaro, N., A. Casagrande, M. Chiara, B. Fosso, C. Manzari, A.M. D'Erchia, S. Iesari, F. Pisani, A. Famulari, P. Tulissi, S. Mastrosimone, M.C. Maresca, G. Mercante, G. Spriano, G. Corrado, E. Vizza, A.R. Garbuglia, M.R. Capobianchi, C. Mottini, A. Cenci, M. Tartaglia, A.N. Costa, G. Pesole, and M. Crescenzi. 2019. No metagenomic evidence of tumorigenic viruses in cancers from a selected cohort of immunosuppressed subjects. Sci Rep. 9:19815.
Per contattare Marco Crescenzi: